Global Lipid Nanoparticles (LNP) Market 2025 by Company, Regions, Type and Application, Forecast to 2031

According to our (Global Info Research) latest study, the global Lipid Nanoparticles (LNP) market size was valued at US$ 487 million in 2024 and is forecast to a readjusted size of USD 784 million by 2031 with a CAGR of 7.1% during review period.

LNPs are liposome-like structures especially geared towards encapsulating a broad variety of nucleic acids (RNA and DNA); and as such, they are the most popular non-viral gene delivery system. Exelead develops and manufactures LNPs to encapsulate different types of genetic payloads including siRNA, mRNA and saRNA.

The world"s core manufacturers of Lipid Nanoparticles include Merck KGaA and others. The largest manufacturer has approximately 70% of the market share. North America is the world"s largest market, accounting for approximately 60% of the market, followed by Europe and Asia Pacific, accounting for 26% and 9%, respectively. Among them, mRNA-lipid nanoparticles and siRNA-lipid nanoparticles accounted for 93% and 5%, respectively. The most used are vaccine drugs and scientific research, accounting for 81% and 19% respectively.

This report is a detailed and comprehensive analysis for global Lipid Nanoparticles (LNP) market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:

Global Lipid Nanoparticles (LNP) market size and forecasts, in consumption value ($ Million), 2020-2031

Global Lipid Nanoparticles (LNP) market size and forecasts by region and country, in consumption value ($ Million), 2020-2031

Global Lipid Nanoparticles (LNP) market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031

Global Lipid Nanoparticles (LNP) market shares of main players, in revenue ($ Million), 2020-2025

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Lipid Nanoparticles (LNP)

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Lipid Nanoparticles (LNP) market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Precision NanoSystems, Evonik, Merck KGaA, Genevant Sciences, Exelead, Avanti Polar Lipids, Nippon Fine Chemical, Lipoid, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market segmentation

Lipid Nanoparticles (LNP) market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
mRNA-lipid Nanoparticle
siRNA-lipid Nanoparticle
Others

Market segment by Application
Vaccines and Drugs
Scientific Research

Market segment by players, this report covers
Precision NanoSystems
Evonik
Merck KGaA
Genevant Sciences
Exelead
Avanti Polar Lipids
Nippon Fine Chemical
Lipoid

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:

Chapter 1, to describe Lipid Nanoparticles (LNP) product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top players of Lipid Nanoparticles (LNP), with revenue, gross margin, and global market share of Lipid Nanoparticles (LNP) from 2020 to 2025.

Chapter 3, the Lipid Nanoparticles (LNP) competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Lipid Nanoparticles (LNP) market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.

Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.

Chapter 12, the key raw materials and key suppliers, and industry chain of Lipid Nanoparticles (LNP).

Chapter 13, to describe Lipid Nanoparticles (LNP) research findings and conclusion.